AAAAAA

   
Results: 1-8 |
Results: 8
No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk
Authors: David-Beabes, GL Lunn, RM London, SJ
Citation: Gl. David-beabes et al., No association between the XPD (Lys751Gln) polymorphism or the XRCC3 (Thr241Met) polymorphism and lung cancer risk, CANC EPID B, 10(8), 2001, pp. 911-912
Polymorphisms in the DNA repair gene XRCC1 and breast cancer
Authors: Duell, EJ Millikan, RC Pittman, GS Winkel, S Lunn, RM Tse, CKJ Eaton, A Mohrenweiser, HW Newman, B Bell, DA
Citation: Ej. Duell et al., Polymorphisms in the DNA repair gene XRCC1 and breast cancer, CANC EPID B, 10(3), 2001, pp. 217-222
DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk
Authors: Stern, MC Umbach, DM van Gils, CH Lunn, RM Taylor, JA
Citation: Mc. Stern et al., DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk, CANC EPID B, 10(2), 2001, pp. 125-131
Expression of cytochrome P450 1A1/2 and 3A4 in liver tissues of hepatocellular carcinoma cases and controls from Taiwan and their relationship to hepatitis B virus and aflatoxin B-1- and 4-aminobiphenyl-DNA adducts
Authors: Zhang, YJ Chen, SY Tsai, WY Ahsan, H Lunn, RM Wang, LY Chen, CJ Santella, RM
Citation: Yj. Zhang et al., Expression of cytochrome P450 1A1/2 and 3A4 in liver tissues of hepatocellular carcinoma cases and controls from Taiwan and their relationship to hepatitis B virus and aflatoxin B-1- and 4-aminobiphenyl-DNA adducts, BIOMARKERS, 5(4), 2000, pp. 295-306
XPD polymorphisms: effects on DNA repair proficiency
Authors: Lunn, RM Helzlsouer, KJ Parshad, R Umbach, DM Harris, EL Sanford, KK Bell, DA
Citation: Rm. Lunn et al., XPD polymorphisms: effects on DNA repair proficiency, CARCINOGENE, 21(4), 2000, pp. 551-555
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
Authors: Lunn, RM Bell, DA Mohler, JL Taylor, JA
Citation: Rm. Lunn et al., Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2), CARCINOGENE, 20(9), 1999, pp. 1727-1731
XRCC1 polymorphisms: Effects on aflatoxin B-1-DNA adducts and glycophorin A variant frequency
Authors: Lunn, RM Langlois, RG Hsieh, LL Thompson, CL Bell, DA
Citation: Rm. Lunn et al., XRCC1 polymorphisms: Effects on aflatoxin B-1-DNA adducts and glycophorin A variant frequency, CANCER RES, 59(11), 1999, pp. 2557-2561
Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase
Authors: Begemann, M Kashimawo, SA Lunn, RM Delohery, T Choi, YJA Kim, S Heitjan, DF Santella, RM Schiff, PB Bruce, JN Weinstein, IB
Citation: M. Begemann et al., Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase, ANTICANC R, 18(5A), 1998, pp. 3139-3152
Risultati: 1-8 |